| Advantages | These organoids provide a reliable platform for studying cholangiocarcinoma progression, tumor biology, and drug screening. Compared to traditional 2D cultures, they offer a more clinically relevant setting for investigating iCCA pathophysiology and evaluating therapeutic candidates. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Liver |
| Disease | Cancer |
| Format | Frozen |
| Organoid Characterization | They faithfully replicate the structural and molecular characteristics of the original tumor, including cholangiocyte differentiation and interactions with the tumor microenvironment. Each batch undergoes rigorous testing for mycoplasma, bacteria, and fungi/yeast, and is validated for identity, genetic stability, and functional performance. |
| Applications | Tissue-derived organoids are extensively utilized in drug screening, disease modeling, mechanistic research, personalized medicine, and regenerative medicine. By recapitulating authentic disease states, they provide a robust platform for evaluating patient-specific drug responses and supporting individualized treatment design. Moreover, these organoids enable the development of innovative therapeutic strategies, especially in cancer research and organ regeneration, delivering precise experimental systems that significantly advance precision medicine. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.